FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
REPRODUCTIVE HEALTH AND OB/GYN

Menopause and hormone therapy.

Menopausal symptoms, hormone therapy benefits and risks, and treatment of vaginal atrophy, vasomotor symptoms and bone loss.

Menopause is defined as 12 months without menses, usually near 51. Hormone therapy decisions depend on symptoms and risks.

Symptoms and labs

Hot flashes, night sweats, vaginal dryness and sleep change. FSH is elevated and estradiol low. Premature ovarian insufficiency is menopause before 40.

Treatment

Systemic hormone therapy is the most effective treatment for vasomotor symptoms in women under 60 or within 10 years of menopause without contraindications. Add a progestin if the uterus is present to prevent endometrial hyperplasia. Risks include venous thromboembolism, stroke and breast cancer. Non-hormonal choices: SSRIs, SNRIs, gabapentin and fezolinetant. Vaginal estrogen treats genitourinary symptoms with little systemic absorption.

Bone and heart

Hormone therapy prevents bone loss but is not first-line for osteoporosis alone, and should not be used to prevent heart disease. Screen with DEXA at 65.

Keep going in reproductive health and ob/gyn

Related on USMLE WEB

Frequently asked questions

When should a progestin be added to estrogen therapy?

When the uterus is present.

What is a non-hormonal drug for hot flashes?

An SSRI, SNRI or gabapentin.